0.1999
Cosmos Health Inc stock is traded at $0.1999, with a volume of 4.31M.
It is up +0.05% in the last 24 hours and down -3.89% over the past month.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
See More
Previous Close:
$0.1998
Open:
$0.2
24h Volume:
4.31M
Relative Volume:
0.52
Market Cap:
$12.41M
Revenue:
$69.49M
Net Income/Loss:
$-21.13M
P/E Ratio:
-0.308
EPS:
-0.649
Net Cash Flow:
$-14.46M
1W Performance:
-14.86%
1M Performance:
-3.89%
6M Performance:
-59.88%
1Y Performance:
-66.11%
Cosmos Health Inc Stock (COSM) Company Profile
Name
Cosmos Health Inc
Sector
Industry
Phone
312-536-3102
Address
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
COSM
Cosmos Health Inc
|
0.1999 | 12.41M | 69.49M | -21.13M | -14.46M | -0.649 |
|
MCK
Mckesson Corp
|
840.90 | 98.45B | 403.43B | 5.10B | 5.41B | 38.47 |
|
COR
Cencora Inc
|
309.89 | 60.29B | 328.68B | 2.55B | 1.56B | 13.03 |
|
CAH
Cardinal Health Inc
|
228.03 | 53.41B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
HSIC
Henry Schein Inc
|
85.47 | 9.74B | 13.38B | 418.00M | 391.00M | 3.3112 |
|
AHG
Akso Health Group Adr
|
1.51 | 1.29B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc Stock (COSM) Latest News
COSM|Cosmos Health Inc|Price:0.200|Chg%:+0.000 - TradingKey
Cosmos Health Inc (COSM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cosmos Health Inc (COSM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Daily Brief Health Care: Shanghai Shengsheng Pharmaceutical Cold Chain Technology, Akeso, Mitesco Inc, Nagaileben, Repligen Corp, Scribe Therapeutics, Cosmos Health and more - Smartkarma
Cosmos Health Inc (COSM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
COSM Marking Huge Growth and Buying Back Shares - Yahoo Finance
Cosmos Health Inc|Price:0.199|Chg%:-0.000 - TradingKey
Cosmos Health | RW: Registration Withdrawal Request - Moomoo
Cosmos Health Inc. SEC Filing (Jul 22, 2026) - Stock Titan
COSM stock trades around recent lows as Cosmos Health focuses on integrating acquisitions and stabil - AD HOC NEWS
Cosmos Health (COSM) Expands Distribution Partnership in Albania - GuruFocus
Cosmos Health expands Pharma Cell partnership i... - Pluang
Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units - GlobeNewswire
Cosmos Health repurchases 5.11 million shares - Medical Buyer
Cosmos Health launches subscription model for health products By Investing.com - Investing.com Nigeria
Cosmos Health repurchases 274,000 shares under buyback program By Investing.com - Investing.com South Africa
BRIEF-Cosmos Health Share Buyback Expands To 5.11 Million Shares - Bitget
Cosmos Health repurchases 274,000 shares under buyback program - Investing.com
Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases - The Manila Times
Cosmos Health Share Buyback Expands To 5.11 Million Shares - TradingView
Cosmos Health (COSM) Expands Share Buyback Program with Additional Purchases - GuruFocus
Cosmos Health shareholders approved Series B preferred stock designation at annual meeting - Bitget
Cosmos Health repurchases 250,000 shares at $0.28 average By Investing.com - Investing.com South Africa
Cosmos Health repurchases 250,000 shares at $0.28 average - Investing.com UK
Price to book forward of Cosmos Health Inc. – NASDAQ:COSM - TradingView
Cosmos Health Inc. Announces Series B Preferred Stock Designation and Director Election Results – July 2026 8-K Filing – Minichart - Minichart
Cosmos Health (NASDAQ: COSM) wins backing for Series B preferred and equity plan - Stock Titan
Cosmos Health Inc. - Via Ritzau
Price to book forward of Cosmos Health Inc – SWB:V67A - TradingView
Cosmos Health repurchases 100,000 shares at $0.29 average By Investing.com - Investing.com South Africa
Cosmos Health (COSM) Boosts Share Buyback Program with Additiona - GuruFocus
Cosmos Health repurchases 100,000 shares at $0.29 average - Investing.com
Cosmos Health Inc. Repurchases Additional 100,000 Shares, Surpasses 4.5 Million Shares Buyback Total - Quiver Quantitative
Cosmos Health Has Spent About $970K on Open-Market Buybacks - Stock Titan
Cosmos Health (COSM) Boosts Share Buyback Program with Recent Pu - GuruFocus
Cosmos Health repurchases 133,000 shares at average $0.298 By Investing.com - Investing.com South Africa
Cosmos Health repurchases 133,000 shares at average $0.298 - Investing.com UK
Cosmos Health: Share Buyback Expands to 4.5M Shares - Moomoo
Cosmos Health Share Buyback Expands To 4.49 Million Shares, Continues Open Market Repurchases - TradingView
Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases - The Manila Times
$Cosmos Health (COSM.US)$ more buy back just now🙂 - Moomoo
Cosmos Health repurchases 215,000 shares at $0.325 average - Investing.com UK
Cosmos Health's Bold Buyback: A Conviction Play or a Risky Bet? - Kavout | AI
Cosmos Health repurchases 215,000 shares at $0.325 average By Investing.com - Investing.com South Africa
Cosmos Health (COSM) Expands Share Repurchase Program with New B - GuruFocus
Cosmos Health Repurchases Additional 215,000 Shares Under $5 Million Buyback Program - Quiver Quantitative
Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases - The Manila Times
Cosmos Health partners with Libytec for diabetes drug in Greece By Investing.com - Investing.com Australia
Cosmos Health Inc Stock (COSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cosmos Health Inc Stock (COSM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Jun 11 '26 |
Buy |
0.21 |
218,447 |
45,000 |
13,481,808 |
| Siokas Grigorios | Chief Executive Officer |
Jun 10 '26 |
Buy |
0.23 |
701,447 |
160,000 |
13,263,361 |
| Siokas Grigorios | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.37 |
388,532 |
145,000 |
8,861,914 |
| Siokas Grigorios | Chief Executive Officer |
Feb 11 '26 |
Buy |
0.41 |
291,262 |
120,000 |
8,473,382 |
| Siokas Grigorios | Chief Executive Officer |
Jan 23 '26 |
Buy |
0.50 |
90,325 |
45,000 |
8,182,120 |
| Siokas Grigorios | Chief Executive Officer |
Jan 20 '26 |
Buy |
0.50 |
353,321 |
175,000 |
8,091,795 |
| Siokas Grigorios | Chief Executive Officer |
Jan 14 '26 |
Buy |
0.45 |
493,495 |
220,000 |
7,738,474 |
| Siokas Grigorios | Chief Executive Officer |
Jan 12 '26 |
Buy |
0.50 |
113,185 |
57,000 |
7,244,979 |
| Siokas Grigorios | Chief Executive Officer |
Jan 08 '26 |
Buy |
0.52 |
156,190 |
81,000 |
7,131,794 |
| Siokas Grigorios | Chief Executive Officer |
Jan 07 '26 |
Buy |
0.52 |
124,880 |
65,000 |
6,975,604 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):